Intervacc sm en

Mon, May 22, 2023 15:20 CET

Photographer: Fotograf

About Us

Intervacc AB is a Swedish company within animal health developing safe, effective vaccines for animals. The Company's vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company´s research and development work. The Intervacc share has been listed on the Nasdaq First North Growth Market since April 2017.

Contacts

Jonas Sohlman
CEO

Box 112, S-129 22 Hägersten Visiting address: Västertorpsvägen 135, S-129
+46 (0) 70 576 30 73
https://www.intervacc.se
jonas.sohlman@intervacc.se

Related Releases

Intervacc identifies a potential short out-of-stock situation regarding Strangvac Fri, Sep 20, 2024 17:37 CET

Intervacc and the Karolinska Institutet extends contract for the development of innovative animal health vaccines Thu, Aug 15, 2024 09:30 CET

Intervacc has presented new findings at the ACVIM Forum in the United States Thu, Jun 13, 2024 11:15 CET

Intervacc sm en

About Us

Contacts

Subscribe

Related Releases